GENENTECH INITIATES PHASE III CLINICAL TRIAL OF ACTEMRA IN HOSPITALIZED PATIENTS WITH SEVERE COVID-19 PNEUMONIA
Other NEWS
- 240 P
Novartis update on FDA review of ofatumumab, a self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis
RECENT POSTS Basel, June 2, 2020 — Novartis today announced that it has received notice from the US Food and Drug Admin ... - 240 PWorld Brain Day: Hot Topics in Parkinson Disease
RECENT POSTS This year, the World Federation of Neurology partnered with the International Parkinson and Movement Disorder Societ ... - 240 PThe Top 5 Posts of July 2020
RECENT POSTSThe U.S. Agency for International Development revamped its Water Office this spring, renaming it the Center for Water S ... - 240 P
How Eating Leafy Greens Can Help People With MS
RECENT POSTS A recent study showed the older adults who eat leafy vegetables had slower rate of memory decline. Experts think this ... - 240 P
High-Dose Biotin Fails in MS Trial
RECENT POSTS Click HERE to Subscribe for the MS Beacon Newsletter reported by : Cherie C Binns RN MSCN — Neither primar ...
0 Comments: